ADMA Biologics, Inc. (ADMA)

USD 17.7

(-4.99%)

Annual Balance Sheets

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 329.18 Million 348.46 Million 276.25 Million 207.67 Million 127.09 Million 88.87 Million
Total Current Assets 257.01 Million 270.4 Million 208.72 Million 153.74 Million 85.82 Million 44.52 Million
Cash And Short Term Investments 51.35 Million 86.52 Million 51.08 Million 55.92 Million 26.75 Million 22.75 Million
Cash and Cash Equivalents 51.35 Million 86.52 Million 51.08 Million 55.92 Million 26.75 Million 22.75 Million
Short Term Investments - - - - - -
Net Receivables 27.42 Million 15.5 Million 28.57 Million 13.23 Million 3.46 Million 1.39 Million
Inventory 172.9 Million 163.28 Million 124.72 Million 81.53 Million 53.06 Million 18.61 Million
Other Current Assets 5.33 Million 5.09 Million 4.33 Million 3.04 Million 2.53 Million 1.76 Million
Total Non-Current Assets 72.16 Million 78.06 Million 67.52 Million 53.93 Million 41.27 Million 44.34 Million
Net PPE 63.47 Million 68.74 Million 58.19 Million 45.85 Million 31.74 Million 30.11 Million
Good Will And Intangible Assets 4.02 Million 4.54 Million 5.25 Million 5.97 Million 6.68 Million 7.53 Million
Good Will 3.53 Million 3.52 Million 3.52 Million 3.52 Million 3.52 Million 3.52 Million
Intangible Assets 499 Thousand 1.01 Million 1.72 Million 2.44 Million 3.15 Million 4 Million
Long-Term Investments - - - - - -
Tax Assets - - - - - -
Other Non Current Assets 4.67 Million 4.77 Million 4.06 Million 2.1 Million 2.84 Million 6.69 Million
Other Assets 1.00 - - - - -
Total Liabilities 193.97 Million 196.48 Million 135.08 Million 119.42 Million 100.89 Million 69.1 Million
Total Current Liabilities 49.8 Million 39.26 Million 30.37 Million 19.94 Million 14.02 Million 9.62 Million
Account Payables 15.66 Million 13.22 Million 12.42 Million 11.07 Million 9.17 Million 5.9 Million
Tax Payables - - - - - -
Short Term Debt 1.04 Million 905.36 Thousand 591.08 Thousand 365.68 Thousand 229.07 Thousand 29.98 Thousand
Deferred Revenue 182 Thousand 142.83 Thousand 142.83 Thousand 142.83 Thousand 142.83 Thousand 142.83 Thousand
Other Current Liabilities 32.91 Million 24.98 Million 17.21 Million 8.36 Million 4.48 Million 3.55 Million
Total Non Current Liabilities 144.17 Million 157.22 Million 104.7 Million 99.47 Million 86.86 Million 59.48 Million
Long-Term Debt 130.59 Million 153.53 Million 102.32 Million 97.3 Million 84.5 Million 44.19 Million
Deferred Revenue Non Current 1.69 Million 1.83 Million 1.97 Million 2.11 Million 2.26 Million 2.4 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 2.1 Million 1.85 Million 397.35 Thousand 54.88 Thousand 106.57 Thousand 53.4 Million
Other Liabilities - - - - - -
Total Equity 135.2 Million 151.97 Million 141.17 Million 88.24 Million 26.19 Million 19.77 Million
Stock Holders Equity 135.2 Million 151.97 Million 141.17 Million 88.24 Million 26.19 Million 19.77 Million
Common Stock 23 Thousand 22.18 Thousand 19.58 Thousand 10.49 Thousand 5932.00 4635.00
Retained Earnings -506.25 Million -478.01 Million -412.11 Million -340.46 Million -264.71 Million -216.43 Million
Accumulated other comprehensive income - - - - - -3.42 Million
Common Stock Equity 135.2 Million 151.97 Million 141.17 Million 88.24 Million 26.19 Million 19.77 Million
Capital Lease Obligation 9.77 Million 11.6 Million 8.05 Million 4.69 Million 1.53 Million 149.06 Thousand
Total Investments - - - - - -
Total Debt 141.41 Million 154.44 Million 102.91 Million 97.66 Million 84.73 Million 44.22 Million
Net Debt 90.06 Million 67.92 Million 51.83 Million 41.74 Million 57.97 Million 21.46 Million

Balance Sheet Charts